NeoGenomics exec surrenders 2,692 shares for tax
NeoGenomics, Inc. (NEO) executive Alicia C. Olivo reported one routine tax-related share disposition and updated her equity award holdings.
Rhea-AI Filing Summary
NeoGenomics, Inc. (NEO) executive Alicia C. Olivo reported one routine tax-related share disposition and updated her equity award holdings. On September 1, 2026, 2,692 shares of common stock were surrendered to NeoGenomics for retirement to satisfy tax obligations upon the vesting of restricted stock, leaving her with 90,875 common shares held directly. The filing also details her outstanding stock options, restricted stock units, and performance stock units across multiple grant dates, with exercise prices ranging from $9.45 to $48.99 and expirations extending to 2036, and no Rule 10b5-1 trading plan is reported.
Positive
- None.
Negative
- None.
Insider Trade Summary
Tax Withholding: 2,692 shares
Tax Withholding
18 txns
Insider
Olivo Alicia C
Role
EVP, GC & Business Development
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Tax Withholding | Common Stock F1 | 2,692 | $0.00 | $0.00 |
| holding | Stock Option (Right to Buy) F2 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F3 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F4 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F5 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F6 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F7 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F8 | -- | -- | -- |
| holding | Restricted Stock Unit F9, F10 | -- | -- | -- |
| holding | Performance Stock Unit F11, F10 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F12 | -- | -- | -- |
| holding | Performance Stock Unit F13, F10 | -- | -- | -- |
| holding | Restricted Stock Unit F14, F10 | -- | -- | -- |
| holding | Restricted Stock Unit F10 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F15, F16 | -- | -- | -- |
| holding | Restricted Stock Unit F17, F10 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F18, F19 | -- | -- | -- |
| holding | Restricted Stock Unit F20, F10 | -- | -- | -- |
Holdings After Transaction:
Common Stock — 90,875 shares (Direct);
Stock Option (Right to Buy) — 406,386 contracts (Direct);
Restricted Stock Unit — 201,556 contracts (Direct);
Performance Stock Unit — 44,838 contracts (Direct)
Footnotes (20)
- F1. Shares surrendered to NeoGenomics, Inc. for retirement to satisfy tax obligations in connection with the September 1, 2026 vesting of restricted stock.
- F2. On September 30, 2019, Ms. Olivo was granted 1,394 stock options. The options vest ratably over the first four anniversary dates of the grant date.
- F3. On May 1, 2020, Ms. Olivo was granted 1,024 stock options. The options vest ratably over the first four anniversary dates of the grant date.
- F4. On May 1, 2021, Ms. Olivo was granted 516 stock options. The options vest ratably over the first four anniversary dates of the grant date.
- F5. On August 1, 2021, Ms. Olivo was granted 1,117 stock options. The options vest ratably over the first four anniversary dates of the grant date.
- F6. On May 1, 2022, Ms. Olivo was granted 22,222 stock options. The options vest ratably over the first four anniversary dates of the grant date.
- F7. On September 1, 2022, Ms. Olivo was granted 55,332 stock options. The options vest ratably over the first four anniversary dates of the grant date.
- F8. On May 11, 2023, Ms. Olivo was granted 36,508 stock options. The options vest ratably over the first three anniversary dates of the grant date.
- F9. On May 11, 2023, Ms. Olivo was granted 19,508 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.
- F10. Once vested, the shares of common stock are not subject to expiration.
- F11. On May 11, 2023, Ms. Olivo was granted 19,508 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 29,262. The number of performance stock units that may vest is based on the achievement of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at theapplicable measurement dates, subject to continued service with the Company.
- F12. On February 23, 2024, Ms. Olivo was granted 42,344 stock options. The options vest ratably over the first three anniversary dates of the grant date.
- F13. On February 23, 2024, Ms. Olivo was granted 25,330 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is37,996. 50% of the number of performance stock units that may vest is based on the achievement of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period atthe applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based on the achievement of certain revenue growth goals based on the achievement of thecumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company.
- F14. On February 23, 2024, Ms. Olivo was granted 25,329 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.
- F15. This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on February 20, 2025 and multiplied by 110%.
- F16. On February 21, 2025, Ms. Olivo was granted 107,450 stock options. The options vest ratably over the first three anniversary dates of the grant date.
- F17. On February 21, 2025, Ms. Olivo was granted 63,238 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.
- F18. This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on February 27, 2026 and multiplied by 110%.
- F19. On March 1, 2026, Ms. Olivo was granted 147,804 stock options. The options vest ratably over the first three anniversary dates of the grant date.
- F20. On March 1, 2026, Ms. Olivo was granted 89,013 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.
Key Figures
Shares surrendered for taxes: 2,692 shares
Direct common shares after transaction: 90,875 shares
Largest option grant: 147,804 options at $10.81
+4 more
7 metrics
Shares surrendered for taxes
2,692 shares
Common stock surrendered September 1, 2026 to satisfy tax obligations on vesting
Direct common shares after transaction
90,875 shares
Common stock directly owned by Alicia C. Olivo following the September 1, 2026 transaction
Largest option grant
147,804 options at $10.81
Stock options on common stock expiring March 1, 2036, held directly
Second-largest option grant
107,450 options at $13.05
Premium-price stock options expiring February 21, 2035, held directly
Recent RSU grant size
89,013 units
Restricted stock units granted March 1, 2026, vesting ratably over three years
2024 PSU target and maximum
25,330 target; 37,996 max shares
Performance stock units granted February 23, 2024, with share-price and revenue goals
2023 PSU target and maximum
19,508 target; 29,262 max shares
Performance stock units granted May 11, 2023, subject to share growth goals
Key Terms
restricted stock units, performance stock units, premium-price stock option, weighted average price, +1 more
5 terms
restricted stock units financial
"On March 1, 2026, Ms. Olivo was granted 89,013 restricted stock units."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
performance stock units financial
"Ms. Olivo was granted 25,330 performance stock units representing the number of shares"
Performance stock units are a type of company award that grants employees shares of stock only if certain performance goals are met. They motivate employees to work toward specific company achievements, aligning their interests with those of shareholders. For investors, they can influence a company's future stock supply and reflect management’s confidence in reaching key targets.
weighted average price financial
"based on the weighted average price of the Company's common stock over the 20-day"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
cumulative fiscal year revenue goal financial
"based on the achievement of the cumulative fiscal year revenue goal at the"
FAQ
What did NeoGenomics (NEO) executive Alicia C. Olivo report in this Form 4?
She reported that 2,692 shares of NeoGenomics common stock were surrendered to the company on September 1, 2026 to satisfy tax obligations from vested restricted stock, and she disclosed her current option, RSU, and PSU holdings.
Was the NeoGenomics (NEO) Form 4 transaction a market sale by Alicia C. Olivo?
No. The Form 4 states that 2,692 shares were surrendered to NeoGenomics for retirement to satisfy tax obligations related to restricted stock vesting, not sold on the open market.
What stock option positions does Alicia C. Olivo hold in NeoGenomics (NEO)?
She holds several stock option grants, including 147,804 options at an exercise price of $10.81 expiring March 1, 2036, and 107,450 options at $13.05 expiring February 21, 2035, plus earlier grants with exercise prices up to $48.99.
What restricted stock unit (RSU) awards are disclosed for Alicia C. Olivo at NeoGenomics (NEO)?
Disclosed RSU positions include 89,013 units from a March 1, 2026 grant and 63,238 units from a February 21, 2025 grant, among others, with units vesting ratably over three years and not expiring once vested.
What performance stock units (PSUs) does Alicia C. Olivo hold in NeoGenomics (NEO)?
She holds 19,508 PSUs from May 11, 2023, with a maximum of 29,262 shares possible, and 25,330 PSUs from February 23, 2024, with a maximum of 37,996 shares based on share-price and revenue growth goals and continued service.
Is Alicia C. Olivo’s NeoGenomics (NEO) Form 4 transaction under a Rule 10b5-1 plan?
No. The filing’s Rule 10b5-1 checkbox is not affirmed; it does not state that the September 1, 2026 tax-withholding transaction was made under a Rule 10b5-1 trading plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
